Engineering of hyaluronan-decorated hybrid lipid/polymer nanoparticles for the dual delivery of miR-181a and temozolomide for the treatment of glioblastoma.
Engineering of hyaluronan-decorated hybrid lipid/polymer nanoparticles for the dual delivery of miR-181a and temozolomide for the treatment of glioblastoma.
批准号:
457631
负责人:
Passos Gibson Victor
金额:
$10.93万
依托单位:
依托单位国家:
加拿大
项目类别:
Studentship Programs
财政年份:
2021
资助国家:
加拿大
项目状态:
已结题
起止时间:
2021-11-01 至 2024-11-01
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Glioblastoma multiforme (GBM) is the most common and lethal primary malignant brain tumour, with patients having a median survival rate of fewer than 15 months. Moreover, the first-line approved therapy, drug temozolomide plus radiotherapy, failed to incr
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金